These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18850430)

  • 1. Cervical cancer: socioeconomic implications of management in a developing nation.
    Obi SN; Ozumba BC
    J Obstet Gynaecol; 2008 Jul; 28(5):526-8. PubMed ID: 18850430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The socio-economic impact of cervical cancer on patients and their families in Argentina, and its influence on radiotherapy compliance. Results from a cross-sectional study.
    Arrossi S; Matos E; Zengarini N; Roth B; Sankaranayananan R; Parkin M
    Gynecol Oncol; 2007 May; 105(2):335-40. PubMed ID: 17258801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opinion of caregivers of some women with breast and cervical cancer on aspects of the disease.
    Ohaeri JU; Campbell OB; Ilesanmi A; Ohaeri BM
    West Afr J Med; 1999; 18(1):6-12. PubMed ID: 10876723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy.
    Ramondetta LM; Sun C; Hollier L; Jarrett L; Folloder J; Tortolero-Luna G; Hughes A; Jhingran A; Brown J
    Gynecol Oncol; 2006 Nov; 103(2):547-53. PubMed ID: 16730784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge, attitude and practice of screening for cervical cancer among female students of a tertiary institution in South Eastern Nigeria.
    Akujobi CN; Ikechebelu JI; Onunkwo I; Onyiaorah IV
    Niger J Clin Pract; 2008 Sep; 11(3):216-9. PubMed ID: 19140357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer: treatment challenges in the developing world.
    Thomas G
    Radiother Oncol; 2006 May; 79(2):139-41. PubMed ID: 16684573
    [No Abstract]   [Full Text] [Related]  

  • 7. The cervical smear pattern in patients with chronic pelvic inflammatory disease.
    Abdul MA; Shittu SO; Randawa JA; Shehu MS
    Niger J Clin Pract; 2009 Sep; 12(3):289-93. PubMed ID: 19803028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making the case for cervical cancer prevention: what about equity?
    Tsu VD; Levin CE
    Reprod Health Matters; 2008 Nov; 16(32):104-12. PubMed ID: 19027628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to cervical and breast cancer programs is crucial to improving screening performance.
    Mauad EC; Nicolau SM; Moreira LF; Haikel RL; Longatto-Filho A; Baracat EC
    Rural Remote Health; 2009; 9(3):1241. PubMed ID: 19778158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
    Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
    Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy interruption in a poor resource setting: causes and management.
    Akinlade BI; Folasire AM; Elumelu-Kupoluyi TN; Adenipekun AA; Iyobosa UB; Campbell OB
    Afr J Med Med Sci; 2014 Dec; 43(4):333-7. PubMed ID: 26234121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapeutic management of cancer of cervix in Nigeria.
    Ducan JT
    Ghana Med J; 1973 Dec; 12(4):374-82. PubMed ID: 4806307
    [No Abstract]   [Full Text] [Related]  

  • 13. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
    Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
    J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria.
    Ogunbowale T; Lawoyin TO
    Aust J Rural Health; 2008 Dec; 16(6):338-42. PubMed ID: 19032205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
    Lowe MP; Chamberlain DH; Kamelle SA; Johnson PR; Tillmanns TD
    Gynecol Oncol; 2009 May; 113(2):191-4. PubMed ID: 19249082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of tailored adjuvant postoperative chemoradiotherapy in IB FIGO stage cervical cancer.
    Fabrini MG; Gadducci A; Perrone F; Cosio S; Laliscia C; Pasqualetti F; Grespi S; Cionini L
    Anticancer Res; 2009 Oct; 29(10):4205-10. PubMed ID: 19846974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct integration of government funding and family support for musculoskeletal tumor care in a resource-constrained country.
    Adegbehingbe OO; Akinyoola AL; Ariyibi AL; Oginni LM
    Oncology; 2009; 76(6):398-404. PubMed ID: 19407472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer: patterns of long-term survival.
    Clemmens DA; Knafl K; Lev EL; McCorkle R
    Oncol Nurs Forum; 2008 Nov; 35(6):897-903. PubMed ID: 18980920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed treatment of symptomatic breast cancer: the experience from Kaduna, Nigeria.
    Ukwenya AY; Yusufu LM; Nmadu PT; Garba ES; Ahmed A
    S Afr J Surg; 2008 Nov; 46(4):106-10. PubMed ID: 19051953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.